Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Ketamine on Epigenetic Age (IKEA)

NCT05294835 is registered in ClinicalTrials.gov with TruDiagnostic as lead sponsor.

NCT NCT05294835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05294835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Ketamine on Epigenetic Age (IKEA)
Lead sponsor
TruDiagnostic
Phase
Phase 2
Overall status
Unknown status
Start date
April 1, 2022
Completion date
December 31, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, post traumatic stress disorder